Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
60 Degrees Pharmaceuticals, Inc. - Common Stock
Biolife Sciences Inc
Canary Staked TRX ETF
Cematrix Corp
Clean Earth Acquisitions Corp. - Class A Common Stock
Conformis, Inc. - Common Stock
Draganfly Inc
Farmers & Merchants Bancorp
Fpx Nickel Corp
Grayscale Bitcoin Cash TR
Janus Henderson Small Cap Growth Alpha ETF
Kidpik Corp. - Common Stock
Medmen Enterprises Inc
Mercari Inc
Metalore Resources Limited
Minehub Technologies Inc
Origin Agritech Limited - Ordinary Shares
Pembina Pipeline Corp. Ordinary Shares (Canada)
ProPhase Labs, Inc. - Common Stock
Salem Media Group, Inc. - Class A Common Stock
Silicon Laboratories, Inc. - Common Stock
Smart Share Global Limited - American Depositary Shares
Stoke Therapeutics, Inc. - Common Stock
Surge Copper Corp
Upstart Holdings, Inc. - Common stock
Vpr Brands LP
West Mining Corp
Xtm Inc
ZW Data Action Technologies Inc. - Common Stock
iShares Morningstar Small-Cap Growth ETF
Edit Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Avista Public Acquisition Corp. II - Class A Ordinary Shares
(NQ:
AHPA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Nov 1, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Avista Public Acquisition Corp. II - Class A Ordinary Shares
OmniAb Business Combination Approved by APAC Shareholders
October 24, 2022
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand Announces that Janssen has Received Approval from European Commission for TECVAYLI® (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
August 24, 2022
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand Reports Second Quarter 2022 Financial Results
August 08, 2022
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand Reports First Quarter 2022 Financial Results
May 04, 2022
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
March 23, 2022
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.